> 数据图表想问下各位网友1.3 港股医药行业2026上半年业绩总览——创新药及制剂2026-9-51.3 港股医药行业2026上半年业绩总览——创新药及制剂部分创新药及制剂企业26H1财务数据（亿元）数据来源：ifind，西南证券整理；*按26H1收入规模排序，市值截至2026/09/0718代码公司荣昌生物-B百济神州复星医药石药集团恒瑞医药信达生物翰森制药联邦制药远大医药丽珠医药先声药业三生制药康哲药业复宏汉霖绿叶制药2024H1382.36160.HK2196.HK203.81177.HK 中国生物制药 159.3162.81093.HK1276.HK136.039.51801.HK65.13692.HK3933.HK71.87.49995.HK56.50512.HK62.81513.HK2096.HK31.143.91530.HK36.10867.HK2696.HK27.530.72186.HK24.60775.HK 长江生命科技22.30013.HK9926.HK10.27.91877.HK13.79688.HK3.01952.HK9969.HK4.213.86990.HK 科伦博泰生物0.16998.HK2142.HK1.70.01167.HK3696.HK4.4再鼎医药-B云顶新耀-B诺诚健华-B嘉和生物-B和铂医药-B加科思-B英矽智能和黄医药康方生物-B君实生物收入2025H1175.2194.3175.7132.7157.659.574.375.210.955.762.735.843.640.028.231.823.819.914.111.715.54.57.39.50.37.30.52.0收入增速归母净利润2026H1222.2203.8194.4185.9154.686.283.061.758.555.350.045.845.345.035.930.023.518.918.117.014.011.511.49.88.78.37.37.22025H144.7%-4.7%10.7%-18.5%15.9%50.6%14.3%4.8%47.6%1.0%-0.2%15.1%-0.8%10.8%2.7%3.5%-1.1%-9.2%37.7%48.6%15.4%48.0%74.3%-31.3%122.8%327.5%0.0%-54.0%2026H126.8%4.9%10.6%40.1%-1.9%44.8%11.7%-18.0%435.7%3.2%-20.3%27.8%3.9%12.5%27.3%-5.6%4.2%0.2%27.9%45.2%-4.9%157.3%55.5%2.9%-23.1%20.9%1500.5%287.2%2024H12025H12026H114.612.230.230.234.3-3.927.314.9-7.814.611.74.610.99.13.93.90.01.9-2.4-6.5-9.8-6.3-2.63.1-1.30.1-1.70.64.517.033.925.544.58.331.318.9-4.510.712.86.013.69.43.93.1-1.432.6-5.7-4.1-6.4-2.5-0.3-1.5-0.55.1-0.6-1.432.717.234.360.944.712.542.63.546.69.29.38.311.59.94.33.9-0.21.1-4.20.3-6.9-0.12.53.9-0.74.46.02.4板块创新药2026H1627.2%1.1%1.4%归母净利润增速2025H1125.7%39.0%12.3%-15.6%29.7%312.5%15.0%27.0%42.4%-25.0%创新药化学制剂化学制剂139.2% 化学制剂化学制剂0.3%50.2%35.8%化学制剂-81.6% 化学制剂1137.1%-13.8% 化学制剂-27.2% 化学制剂37.3%化学制剂-15.6% 化学制剂化学制剂创新药9.4%32.2%24.6%3.4%1.0%-19.3%-15168.6%1663.3%-138.9%36.0%33.3%60.5%88.5%-146.8%59.6%4936.4%65.1%-339.3%4.8%10.3%24.8%81.9%-96.7%25.6%106.2%-8.4%97.6%918.7%367.3%-21.3%-14.2%1118.1%275.5%创新药化学制剂创新药创新药创新药创新药创新药创新药创新药创新药创新药创新药创新药创新药总市值(亿元)296156388496430561528190214357915021425735223130965471697652911989627610142911342240西南证券健康医疗
